Companies: 10,795·Total market cap: $144.5T
BioVie Inc.

BioVie Inc.

BIVINASDAQHealthcare● Active
$1.67
+$0.07(+4.38%)
Market Cap$12594871
P/E Ratio
52W High$12.1
52W Low$1.06
Overview

BioVie Inc.(BIVI)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BIVI · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.47bivi eps ttm · bivi earnings per shareEarnings history
PE Ratio (TTM)bivi pe ratio ttm · bivi price to earningsPE Ratio deep dive
Revenue (TTM)0.00bivi revenue ttm · bivi annual revenueFull revenue history
Dividend Yield不分红does bivi pay dividends · bivi dividend yieldDividend history
Shares Outstanding1.5Mbivi shares outstanding · bivi floatShares outstanding history
Next EarningsSep 2, 2026Est.bivi earnings date · bivi next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
biovie inc. revenue · bivi revenue 2025
FY 2025Net Income-$17.5M▲ +45.39% YoY
202320242025
biovie inc. net income · bivi profit 2025
FY 2025EPS$-12.12▲ +83.41% YoY
202320242025
bivi eps · biovie inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$19.9MEPS: $-1.47View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy5 位分析师is bivi a buy · bivi analyst rating
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$1.67Current
$Avg Target
$High
bivi price target · bivi 12 month forecast

合计: 5 · 买入占比: 100.0%

股票表现

完整历史
1D+4.38%
1W+2.45%
1M+13.61%
3M+22.79%
YTD+43.97%
1Y-85.09%
5Y-99.89%

关于 BioVie Inc.

CEOCuong Viet Do
IPO DateSep 18, 2020
Employees14
CountryUS

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's develo…

what is biovie inc. · bivi stock overview · biovie inc. company profile · who is biovie inc. ceo · bivi NASDAQ · biovie inc. headquarters · biovie inc. business segments

关于股票概览与关键数据

BioVie Inc.(BIVI)是 Biotechnology 行业的 Healthcare 类公司,于 Sep 18, 2020 在 NASDAQ 上市。截至最近交易日,BIVI 股价为 $1.67,市值约为 $12.6M。过去12个月累计回报 -85.09%,年初至今回报 +43.97%。

根据 5 位华尔街分析师,BioVie Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 BioVie Inc. 营收 —,净利润 -$17.5M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,BioVie Inc.(BIVI)股价为 $1.67,在 NASDAQ 上市,52周区间为 $1.06 – $12.10。

BIVI 最新股价BIVI quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议